- Report
- November 2025
- 200 Pages
Global
From €7312EUR$7,950USD£6,230GBP
- Report
- November 2025
- 200 Pages
Global
From €7312EUR$7,950USD£6,230GBP
- Report
- November 2025
- 200 Pages
Global
From €7312EUR$7,950USD£6,230GBP
- Report
- November 2025
- 200 Pages
Global
From €7312EUR$7,950USD£6,230GBP
- Report
- July 2026
- 200 Pages
Global
From €7349EUR$7,990USD£6,261GBP
- Report
- January 2026
- 500 Pages
Global
From €4599EUR$5,000USD£3,918GBP
- Report
- January 2026
- 100 Pages
Global
From €2299EUR$2,500USD£1,959GBP
- Report
- April 2026
- 180 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- April 2026
- 195 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- April 2026
- 120 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- May 2026
- 350 Pages
Global
From €4552EUR$4,949USD£3,878GBP
- Report
- May 2026
- 150 Pages
Global
From €2565EUR$2,789USD£2,186GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2565EUR$2,789USD£2,186GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2565EUR$2,789USD£2,186GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2565EUR$2,789USD£2,186GBP
- Report
- May 2026
- 400 Pages
Global
From €4552EUR$4,949USD£3,878GBP
- Report
- May 2026
- 150 Pages
Global
From €2565EUR$2,789USD£2,186GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2565EUR$2,789USD£2,186GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2565EUR$2,789USD£2,186GBP
- Report
- May 2026
- 200 Pages
Global
From €2565EUR$2,789USD£2,186GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more